AstraZeneca PLC is 205.5x more valuable than ARDELYX, INC. by market capitalization ($286.27 B vs $1.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARDX | AZN |
|---|---|---|
| Market cap | $1.39 B | $286.27 B |
| US-listed rank | #2387 | #45 |
| Revenue (latest FY) | $407.32M | - |
| Net income (latest FY) | -$62.00M | - |
| Net margin | -15.2% | - |
| SEC filings | 1,143 | 1,004 |
AstraZeneca PLC is 205.5x more valuable than ARDELYX, INC. by market capitalization ($286.27 B vs $1.39 B).
Full pages: ARDELYX, INC. and AstraZeneca PLC, or browse the full rankings.